CO2022000040A2 - Vesículas extracelulares microbianas procesadas - Google Patents
Vesículas extracelulares microbianas procesadasInfo
- Publication number
- CO2022000040A2 CO2022000040A2 CONC2022/0000040A CO2022000040A CO2022000040A2 CO 2022000040 A2 CO2022000040 A2 CO 2022000040A2 CO 2022000040 A CO2022000040 A CO 2022000040A CO 2022000040 A2 CO2022000040 A2 CO 2022000040A2
- Authority
- CO
- Colombia
- Prior art keywords
- extracellular vesicles
- processed microbial
- microbial extracellular
- processed
- pmev
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
En el presente documento se proporcionan métodos y composiciones farmacéuticas relacionados con vesículas extracelulares microbianas procesadas (pmEV) que pueden ser útiles como agentes terapéuticos.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962860049P | 2019-06-11 | 2019-06-11 | |
US201962860029P | 2019-06-11 | 2019-06-11 | |
US202062979545P | 2020-02-21 | 2020-02-21 | |
US202062991767P | 2020-03-19 | 2020-03-19 | |
PCT/US2020/037210 WO2020252149A1 (en) | 2019-06-11 | 2020-06-11 | Processed microbial extracellular vesicles |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2022000040A2 true CO2022000040A2 (es) | 2022-01-17 |
Family
ID=71950732
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2022/0000040A CO2022000040A2 (es) | 2019-06-11 | 2022-01-05 | Vesículas extracelulares microbianas procesadas |
CONC2022/0000041A CO2022000041A2 (es) | 2019-06-11 | 2022-01-05 | Vesículas extracelulares microbianas secretadas |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2022/0000041A CO2022000041A2 (es) | 2019-06-11 | 2022-01-05 | Vesículas extracelulares microbianas secretadas |
Country Status (12)
Country | Link |
---|---|
US (2) | US20220249579A1 (es) |
EP (2) | EP3982987A1 (es) |
JP (2) | JP2022537684A (es) |
KR (2) | KR20220020894A (es) |
CN (2) | CN114096262A (es) |
AU (2) | AU2020291434A1 (es) |
BR (2) | BR112021024830A2 (es) |
CA (2) | CA3143025A1 (es) |
CO (2) | CO2022000040A2 (es) |
MX (2) | MX2021015427A (es) |
TW (2) | TW202128198A (es) |
WO (2) | WO2020252149A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200118100A (ko) * | 2018-02-06 | 2020-10-14 | 에벨로 바이오사이언시즈, 인크. | 베일로넬라 박테리아를 이용한 암 및 면역 장애를 치료하기 위한 조성물 및 방법 |
KR102286042B1 (ko) * | 2019-01-09 | 2021-08-03 | 주식회사 엠디헬스케어 | 데이노코커스 속 세균 유래 나노소포 및 이의 용도 |
WO2021252861A1 (en) * | 2020-06-11 | 2021-12-16 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using megasphaera sp |
EP4164666A2 (en) * | 2020-06-11 | 2023-04-19 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using harryflintia acetispora |
KR20230053609A (ko) * | 2020-07-21 | 2023-04-21 | 에벨로 바이오사이언시즈, 인크. | 신경염증성 질환에 대한 경구 요법으로서의 베일로넬라 파르불라 균주 |
WO2022061119A1 (en) * | 2020-09-21 | 2022-03-24 | Evelo Biosciences, Inc. | Compositions and methods for modulating immune responses with prevotella histicola |
KR20230137968A (ko) * | 2021-01-26 | 2023-10-05 | 에벨로 바이오사이언시즈, 인크. | 프레보텔라 세포외 소포체 제제 |
WO2022178209A1 (en) * | 2021-02-19 | 2022-08-25 | Evelo Biosciences, Inc. | Compositions and methods for treating metabolic diseases and disorders using christensenellaceae bacteria |
WO2022221183A1 (en) * | 2021-04-12 | 2022-10-20 | Evelo Biosciences, Inc. | Fournierella extracellular vesicle preparations |
WO2022251166A2 (en) * | 2021-05-25 | 2022-12-01 | Evelo Biosciences, Inc. | Bacterial compositions comprising soy hemoglobin |
WO2023114300A1 (en) * | 2021-12-14 | 2023-06-22 | Evelo Biosciences, Inc. | Fournierella massiliensis bacteria extracellular vesicle preparations |
WO2023114293A1 (en) * | 2021-12-14 | 2023-06-22 | Evelo Biosciences, Inc. | Extracellular vesicle assays |
WO2023146843A1 (en) * | 2022-01-25 | 2023-08-03 | Evelo Biosciences, Inc. | Extracellular vesicle compositions and methods of use |
WO2023239728A1 (en) * | 2022-06-07 | 2023-12-14 | Evelo Biosciences, Inc. | Compositions and methods of treating inflammation using prevotella histicola extracellular vesicles |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101858840B1 (ko) * | 2016-01-15 | 2018-05-16 | 단국대학교 천안캠퍼스 산학협력단 | 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제 |
AU2018298087A1 (en) * | 2017-07-05 | 2020-01-23 | Evelo Biosciences, Inc. | Compositions and methods of treating cancer using bifidobacterium animalis ssp. lactis |
TW201920648A (zh) * | 2017-08-29 | 2019-06-01 | 美商艾弗洛生物科技股份有限公司 | 使用布勞特氏(blautia)菌株治療癌症 |
CN111148531A (zh) * | 2017-09-08 | 2020-05-12 | 伊夫罗生物科学公司 | 细菌胞外囊泡 |
KR20200053532A (ko) * | 2017-09-08 | 2020-05-18 | 에벨로 바이오사이언시즈, 인크. | 프레보텔라로부터의 세포외 소포 |
EP3710023A1 (en) * | 2017-11-14 | 2020-09-23 | Evelo Biosciences, Inc. | Compositions and methods for treating disease using a blautia strain |
KR20200090189A (ko) * | 2017-11-15 | 2020-07-28 | 에벨로 바이오사이언시즈, 인크. | 면역조절 락토코쿠스 박테리아 균주를 사용하여 면역 장애를 치료하기 위한 조성물 및 방법 |
CN109580960A (zh) * | 2019-01-14 | 2019-04-05 | 周明 | 细胞外囊泡的分离方法、以及检测细胞外囊泡表面标志物的方法和试剂盒 |
-
2020
- 2020-06-11 CA CA3143025A patent/CA3143025A1/en active Pending
- 2020-06-11 EP EP20751724.4A patent/EP3982987A1/en active Pending
- 2020-06-11 CN CN202080043264.9A patent/CN114096262A/zh active Pending
- 2020-06-11 CN CN202080042991.3A patent/CN114650831A/zh active Pending
- 2020-06-11 CA CA3143036A patent/CA3143036A1/en active Pending
- 2020-06-11 AU AU2020291434A patent/AU2020291434A1/en not_active Abandoned
- 2020-06-11 WO PCT/US2020/037210 patent/WO2020252149A1/en unknown
- 2020-06-11 US US17/618,679 patent/US20220249579A1/en active Pending
- 2020-06-11 AU AU2020291003A patent/AU2020291003A1/en not_active Abandoned
- 2020-06-11 KR KR1020227000648A patent/KR20220020894A/ko unknown
- 2020-06-11 BR BR112021024830A patent/BR112021024830A2/pt not_active Application Discontinuation
- 2020-06-11 EP EP20751723.6A patent/EP3982986A1/en active Pending
- 2020-06-11 US US17/618,725 patent/US20220296654A1/en active Pending
- 2020-06-11 JP JP2021573416A patent/JP2022537684A/ja active Pending
- 2020-06-11 MX MX2021015427A patent/MX2021015427A/es unknown
- 2020-06-11 KR KR1020227000647A patent/KR20220020893A/ko unknown
- 2020-06-11 TW TW109119718A patent/TW202128198A/zh unknown
- 2020-06-11 BR BR112021024754A patent/BR112021024754A2/pt not_active Application Discontinuation
- 2020-06-11 JP JP2021573327A patent/JP2022538765A/ja active Pending
- 2020-06-11 TW TW109119717A patent/TW202114718A/zh unknown
- 2020-06-11 WO PCT/US2020/037201 patent/WO2020252144A1/en unknown
- 2020-06-11 MX MX2021015429A patent/MX2021015429A/es unknown
-
2022
- 2022-01-05 CO CONC2022/0000040A patent/CO2022000040A2/es unknown
- 2022-01-05 CO CONC2022/0000041A patent/CO2022000041A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA3143036A1 (en) | 2020-12-17 |
WO2020252144A1 (en) | 2020-12-17 |
EP3982986A1 (en) | 2022-04-20 |
KR20220020893A (ko) | 2022-02-21 |
BR112021024830A2 (pt) | 2022-04-12 |
CA3143025A1 (en) | 2020-12-17 |
KR20220020894A (ko) | 2022-02-21 |
US20220296654A1 (en) | 2022-09-22 |
MX2021015429A (es) | 2022-01-24 |
BR112021024754A2 (pt) | 2022-04-19 |
AU2020291003A1 (en) | 2022-01-06 |
AU2020291434A1 (en) | 2022-01-06 |
CO2022000041A2 (es) | 2022-01-17 |
WO2020252149A1 (en) | 2020-12-17 |
JP2022537684A (ja) | 2022-08-29 |
JP2022538765A (ja) | 2022-09-06 |
US20220249579A1 (en) | 2022-08-11 |
EP3982987A1 (en) | 2022-04-20 |
TW202114718A (zh) | 2021-04-16 |
CN114096262A (zh) | 2022-02-25 |
CN114650831A (zh) | 2022-06-21 |
MX2021015427A (es) | 2022-01-24 |
TW202128198A (zh) | 2021-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2022000040A2 (es) | Vesículas extracelulares microbianas procesadas | |
CO2020004233A2 (es) | Vesículas extracelulares bacterianas | |
CO2021012176A2 (es) | Preparaciones de membrana bacteriana | |
DOP2019000005A (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2 | |
MX2020002660A (es) | Vesiculas extracelulares de prevotella. | |
CL2020002821A1 (es) | Piridazinonas como inhibidoras de parp7. | |
CO2020005887A2 (es) | Compuestos policíclicos como inhibidores alostéricos de shp2 | |
CL2018001685A1 (es) | Compuestos heterociclicos como inmuno moduladores. | |
CO2018003678A2 (es) | Composiciones y métodos para inhibir la expresión génica de lpa | |
AR113881A1 (es) | Composiciones y métodos para el tratamiento de desórdenes inmunes usando la cepa blautia | |
CL2016002516A1 (es) | “compuestos derivados de espirociclo sustituidos, inhibidores atx; composición farmacéutica que los comprende; y su uso en el tratamiento del cáncer, inflamaciones, dolor neuropático, enfermedades fibróticas, trombosis, entre otros”. pct | |
CL2019003398A1 (es) | Inhibidores pirazólicos de magl. | |
EA201692334A1 (ru) | Кортикостероидные композиции для местного применения | |
PL410665A1 (pl) | Inhibitory arginazy oraz ich zastosowania terapeutyczne | |
CL2017000845A1 (es) | Inhibidores de gingipaina de lisina | |
CO2021001172A2 (es) | Composiciones y métodos para el tratamiento de enfermedades o condiciones relacionadas con inflamasomas | |
CO2023000114A2 (es) | Composiciones y métodos para el tratamiento de enfermedades y trastornos usando vesículas extracelulares microbianas de oscillospiraceae | |
ECSP20082988A (es) | Agonistas de tlr7 | |
CO6761294A2 (es) | Derivados de pirazol que modulan la estearoil-coa-desaturasa | |
DOP2019000221A (es) | Derivados de pirazol como inhibidores de bromodominio | |
GT201100039A (es) | Agentes antifúngicos | |
TR201908151T4 (tr) | İzoindolin türevleri. | |
BR112022004777A2 (pt) | Composição de micela de estimulação imunológica | |
AR120058A1 (es) | Vesículas extracelulares microbianas procesadas | |
AR122608A1 (es) | Composiciones y métodos para el tratamiento de enfermedades y trastornos usando harryflintia acetispora |